SCHEMBL2433549

SCHEMBL2433549

CC[C@H](C)[C@@H](C(=O)OC(C)(C)C)N1CCNC1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.36
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
NPSR1 Q6W5P4 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
FAAH O00519 1/20 0.32
NAAA Q02083 1/20 0.32
CTSL P07711 1/20 0.32
TSHR P16473 1/20 0.32
PLA2G10 O15496 1/20 0.31
PLA2G5 P39877 1/20 0.31
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22152235 0.85 MAPK1 (0.35) MAPK1MAPTNPSR1CTSLPLA2G10
SCHEMBL28657275 0.85 MAPK1 (0.35) MAPK1MAPTNPSR1CTSLPLA2G10
SCHEMBL2441047 0.81 FAAH (0.36) FAAHNAAATSHRPOLBDPP4
SCHEMBL8234473 0.81 FAAH (0.36) FAAHNAAAPOLBDPP4ALDH1A1
SCHEMBL26097774 0.81 MAPK1 (0.36) MAPK1MAPTKMT2AMEN1NPSR1
SCHEMBL1058021 0.78 MEN1 (0.32) MAPK1MAPTL3MBTL1KMT2AMEN1
SCHEMBL2435477 0.77 MAPK1 (0.35) MAPK1MAPTNPSR1
SCHEMBL27908046 0.70 MAPK1 (0.32) MAPK1PLA2G10PLA2G5
SCHEMBL2433553 0.69 FAAH (0.32) FAAHNAAATSHRPOLBALDH1A1
SCHEMBL22648651 0.69 MAPK1 (0.42) MAPK1MAPTL3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697344-B1 HIV PROTEASE INHIBITING COMPOUNDS ABBOTT LAB (US) 2011-09-28 EP disclosed
US-7834043-B2 Prevent reproduct of aids virus ABBOTT LABORATORIES (US) 2010-11-16 US disclosed
US-20100249181-A1 HIV Protease Inhibiting Compounds ABBOTT LABORATORIES (US) 2010-09-30 US disclosed
US-20050148623-A1 Prevent reproduct of aids virus ABBVIE INC. 2005-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148623-A1 Prevent reproduct of aids virus SERPINB1, PRSS1, SERPINA3 MAPK1 3015/4885MAPT 1745/4885L3MBTL1 1364/4885
US-20100249181-A1 HIV Protease Inhibiting Compounds SERPINB1, HPN, DNPEP MAPK1 3507/4885MAPT 2176/4885L3MBTL1 2883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.